Practice Advantage

Part 1 - Growing Your Practice with Cryopreserved Amniotic Membranes with Dr. Mila Ioussifova and Roger Kennedy

Episode Summary

Amniotic membranes provide a huge practice growth opportunity and way of driving improved clinical outcomes for patients with ocular surface disease. In this first of two parts, we dive into the role cryopreserved amniotic membranes play in practice.

Episode Notes

In today's episode, I sit down with Dr. Mila Ioussifova and Roger Kennedy to discuss the clinical and business impacts of cryopreserved amniotic membranes in practice, especially with patients with dry eye. 

Key Takeaways:

  1. The easiest way to bring amniotic membranes into your practice are by just doing it. Learn about application tools, patient education, billing and coding from the companies themselves and just go for it.
  2. Amniotic membranes aren't just for train wrecks. Persistent ocular surface disease, reduced corneal sensitivity, and moderate dry eye are all great cases for amniotic membrane use.
  3. Knowing the patient's deductible status ahead of time aids in the conversation. Dr. Mila presents amniotic membranes as one of hte only treatments that are covered/ billable to insurance and it's the only regenerative approach to corneal tissue and nerves. Knowing the deductible status prevents the patient from being surprised. The wow effect matters.
  4. Don't be afraid to publicly market your dry eye and amniotic membrane treatments to patients on your website and patient communication. Have a word of mouth strategy and execute it.
  5. Communicate the service and value of your products to other specialists in the area treating patients with conditions that cause dry eye.

What Mila and Roger are reading:

** Don't miss out on an extra $5 rebate for all commercial VSP Eye Exams extended through December 31, 2024. Earn up to an additional $15,000 in 2023 and up to $30,000 in 2024. Visit www.pecaaexamrebate.com now!**